Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

N/ARecruitingNCT05390424

University Hospital, Rouen500 enrolled

Overview

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

500

Conditions

Hepatitis B Hepatitis C AIDS

Interventions

Blood collection using Dried Blood SpotDIAGNOSTIC_TEST

Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Former or active intravenous and/or nasal drug user * Person on opiate substitution therapy Exclusion Criteria: * Person with known active viral infection(s)

Locations (11)

Caarud Sud Manche

Avranches, France

RECRUITING

Csapa Barentin

Barentin, France

RECRUITING

Oeuvre Normande Des Meres

Dieppe, France

Outcomes

Primary Outcomes

Number of person with an active hepatitis C infection

Time frame: Day 1

Number of person with an active hepatitis B infection

Time frame: Day 1

Number of person with an active AIDS infection

Time frame: Day 1

Central Contacts

Ghassan RIACHI, MD

CONTACT

+3323288 ghassan.riachi@chu-rouen.fr

Julien BLOT

CONTACT

+3323288 julien.blot@chu-rouen.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.